| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Investor Reference Pack to 30 June 2025
|
28 Aug 2025 8:42AM |
$5.380 |
$5.060 |
fallen by
5.95%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Atlas Arteria operates major toll roads like APRR, Chicago Skyway, and Dulles Greenway.
- ALX is traded on the Australian Securities Exchange.
- The company has a stable credit rating with positive financial metrics.
- Net debt to EBITDA ratios are maintained at healthy levels.
- Significant traffic volumes and toll revenues are reported for H1 2025.
- Strategic refinancing efforts and toll adjustments are addressed.
- Future growth prospects and investment strategies are outlined.
- Cash flow projections and distribution plans to stakeholders are included.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Half Year Results Investor Presentation to 30 June 2025
|
28 Aug 2025 8:40AM |
$5.380 |
$5.060 |
fallen by
5.95%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax of A$73.3 million, down 32.9% due to TST impact.
- Proportional toll revenue up 8.1% to A$954.5 million.
- Proportional EBITDA increased by 7.8% to A$729.2 million.
- Free cash flow per security increased by 9.0%.
- Distribution guidance maintained at 40 cps.
- FX hedging program implemented for distribution guidance period.
- Pursuing growth opportunities with Eiffage on A412 and A154 projects.
- Dulles Greenway traffic growth due to congestion on competing routes.
- Legal proceedings ongoing for Dulles Greenway rate case and federal litigation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Half Year Results Announcement to 30 June 2025
|
28 Aug 2025 8:39AM |
$5.380 |
$5.060 |
fallen by
5.95%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax of $73.3 million, impacted by temporary supplemental tax.
- Reaffirmed 2025 distribution guidance of 40.0 cents per security.
- Proportionate toll revenue grew by 8.1% compared to H1 2024.
- Focused on growth projects in partnership with Eiffage in France.
- Continued legal proceedings and rate case applications for Dulles Greenway.
- Atlas Arteria's CEO highlights strong first half performance and strategic vision.
- Efficient management of capital and costs emphasized for long-term value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Appendix 4D and Interim Financial Report
|
28 Aug 2025 8:37AM |
$5.380 |
$5.060 |
fallen by
5.95%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Atlas Arteria ('ALX') consists of Atlas Arteria International Limited ('ATLIX') and Atlas Arteria Limited ('ATLAX').
- ATLIX is incorporated and domiciled in Bermuda, while ATLAX is incorporated and domiciled in Australia.
- The financial report covers the first half of the year ending 30 June 2025.
- Revenue from ordinary activities increased by 11.4% to A$77.5 million.
- Net profit after tax attributable to stapled security holders decreased by 32.9% to A$73.3 million.
- The net tangible asset backing per stapled security was A$2.77 as of 30 June 2025.
- Distributions include dividends of 20 cents per security declared for the periods ending March and September 2024.
- ALX's investments include entities like MAF2 in Luxembourg, and CCPI in the USA.
- Significant changes in the state of affairs were not reported by the Directors for the half year.
- No post-balance sheet events significantly affecting operations were reported.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Appendix 4D and Interim Financial Report
|
28 Aug 2025 8:37AM |
$5.380 |
$5.060 |
fallen by
5.95%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Atlas Arteria's interim financial report covers the half-year ended 30 June 2025.
- ALX's equity decreased from $6,340.7 million to $6,115.9 million in the first half of 2025.
- Key financial results include a profit before tax of $74.0 million for ALX.
- Toll revenue and other operating expenses are detailed, contributing to overall financial outcomes.
- Atlas Arteria focuses on optimizing performance, enhancing competitive positioning, and managing capital efficiently.
- Comprehensive income and dividends impacted the equity decrease.
- The report provides detailed financial metrics and notes consolidation of equity for ATLIX and ATLAX securityholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Change in substantial holding
|
7 Aug 2025 8:25AM |
$5.280 |
$5.060 |
fallen by
4.17%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Notice of H1 2025 Results Presentation
|
31 Jul 2025 8:23AM |
$5.220 |
$5.060 |
fallen by
3.07%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Q2 Toll Revenue and Traffic and France Conference Update
|
30 Jul 2025 8:30AM |
$5.190 |
$5.060 |
fallen by
2.50%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- 10.7% increase in toll revenue for Q2 2025.
- APRR traffic positively impacted by timing of Easter.
- Recommendations to maintain concession-based model for tolls in France.
- French government's support for updated concession terms.
- Toll increases impacted light vehicle traffic, particularly in Chicago.
- Dulles Greenway experienced strong traffic growth.
- Traffic was reduced at the Warnow Tunnel due to maintenance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Q2 Toll Revenue and Traffic and France Conference Update
|
30 Jul 2025 8:30AM |
$5.190 |
$5.060 |
fallen by
2.50%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Atlas Arteria reported a 10.7% increase in toll revenue for Q2 2025.
- APRR traffic increased by 3.0%, with toll revenue up by 3.3%.
- A79 and ADELAC showed strong revenue growth.
- Dulles Greenway reported strong traffic and revenue growth.
- The French government supports the updated concession model.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Virginia Supreme Court decision re. SCC Rate Case appeal
|
18 Jul 2025 8:28AM |
$5.170 |
$5.060 |
fallen by
2.13%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Virginia Supreme Court affirmed SCC's decision denying TRIP II's toll rate application.
- TRIP II's federal case will proceed, alleging constitutional violations.
- TRIP II plans to submit a new rate application.
- Atlas Arteria operates toll roads in France, Germany, and the United States.
- The company focuses on sustainable management and stakeholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Notification of cessation of securities - ALX
|
11 Jul 2025 3:47PM |
$5.045 |
$5.060 |
risen by
0.30%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Notification regarding unquoted securities - ALX
|
10 Jul 2025 12:56PM |
$5.095 |
$5.060 |
fallen by
0.69%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Ceasing to be a substantial holder
|
26 Jun 2025 8:23AM |
$5.130 |
$5.060 |
fallen by
1.36%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Change of registry address notification
|
12 Jun 2025 4:43PM |
$5.370 |
$5.060 |
fallen by
5.77%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Company Secretary Appointment/Resignation
|
27 May 2025 2:46PM |
$5.215 |
$5.060 |
fallen by
2.97%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Notification regarding unquoted securities - ALX
|
23 May 2025 5:11PM |
$5.260 |
$5.060 |
fallen by
3.80%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Change of Director's Interest - Hugh Wehby
|
23 May 2025 4:54PM |
$5.260 |
$5.060 |
fallen by
3.80%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
APRR Prices EUR500 million of Eurobonds
|
20 May 2025 8:50AM |
$5.240 |
$5.060 |
fallen by
3.44%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Change in substantial holding - IFM
|
19 May 2025 5:44PM |
$5.240 |
$5.060 |
fallen by
3.44%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
New Atlas Arteria Ltd Constitution
|
16 May 2025 12:47PM |
$5.205 |
$5.060 |
fallen by
2.79%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
New Atlas Arteria International Ltd Bye-Laws
|
16 May 2025 12:46PM |
$5.205 |
$5.060 |
fallen by
2.79%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Results of Meeting
|
15 May 2025 12:19PM |
$5.160 |
$5.060 |
fallen by
1.94%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
2025 AGM Speeches
|
15 May 2025 9:49AM |
$5.140 |
$5.060 |
fallen by
1.56%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Presentation to 2025 Macquarie Australia Conference
|
8 May 2025 8:26AM |
$5.130 |
$5.060 |
fallen by
1.36%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,343 |
Resignation of Joint Company Secretary
|
1 May 2025 3:37PM |
$5.240 |
$5.060 |
fallen by
3.44%
|
|